Biovista

Private

Charlottesville, VirginiaHealthcare & Life Scienceshttps://biovista.com/

Last Round

Grant

Mar 6, 2012

Total Funding Raised

$500,000

Company Overview

Biovista is a biotechnology company that has developed an artificial intelligence-based platform intended to deliver custom drug repositioning, drug de-risking, and clinical hold services for the biopharma industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS, Government Contracts, Freemium, Data as a Service

AI Layer

Application

Keywords

drug repositioningdrug repurposingAI drug discoverydrug de-riskingin silico drug discoverycomputational drug discoveryadverse event predictionAI platformbiopharmaceutical servicesmechanism of actionpersonalized medicinebiomedical literature miningorphan diseasesneurodegenerative diseasesoncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biovista Comps

Public and private peers based on sector, stage, and business model.

Biovista comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biovista Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Mar 6, 2012
Grant	May 5, 2011

View all Funding Rounds

Key People

Founding team and executive leadership

Graham Anthony

Chief Financial Officer, Board Member & Investor

Executive Team

Biovista Investors

Notable investors and investment history

Biovista investors
Investor	Rounds
Solve ME/CFS Initiative	Grant
European Union Seventh Framework Programme	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 5, 2011
$500K grant received from the European Union's Framework Programme 7.

View all signals

Biovista Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biovista Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biovista's valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlottesville, Virginia

Employee Range23

Year Founded1999

Last FundingMar 6, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.